Meta-Analysis of Mortality in Dialysis Patients With an Implantable Cardioverter Defibrillator

American Journal of Cardiology

Volumn 103, Issue 5, 2009, Pages 735-741

  Sakhuja, Rahul ^a   Keebler, Mary ^a   Lai, Tai Shuan ^b   McLaughlin Gavin, Cara ^c   Thakur, Ranjan ^d   Bhatt, Deepak L ^c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c VA BOSTON HEALTHCARE SYSTEM   (United States)

^d MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ARTICLE; BIBLIOGRAPHIC DATABASE; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; DEFIBRILLATOR; DIALYSIS; EMBASE; HUMAN; KIDNEY FUNCTION; MEDLINE; META ANALYSIS; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; SUDDEN DEATH; SURVIVAL; SYSTEMATIC REVIEW;

ADRENERGIC BETA-ANTAGONISTS; ANTI-ARRHYTHMIA AGENTS; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; HUMANS; KIDNEY FAILURE, CHRONIC; RENAL DIALYSIS;

EID: 60449120777     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.11.014     Document Type: Article

References (23)

1. United States Renal Data System. USRDS 2007 Annual Data Report (2007), National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland
2. Moss A.J., Hall W.J., Cannon D.S., Daubert J.P., Higgins S.L., Klein H., Levine J.H., Saksena S., Waldo A.L., Wilber D., et al., Multicenter Automatic Defibrillator Implantation Trial Investigators. Improved survival with an implantable defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 335 (1996) 1933-1940
3. Buxton A.E., Lee K.L., DiCarlo L., Gold M.R., Greer G.S., Prystowsky E.N., O'Toole M.F., Tang A., Fisher J.D., Coromilas J., et al., Multicenter Unsustained Tachycardia Trial Investigators. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. N Engl J Med 342 (2000) 1937-1945
4. Moss A.J., Zareba W., Hall W.J., Klein H., Wilber D.J., Cannom D.S., Daubert J.P., Higgins S.L., Brown M.W., Andrews M.L., and Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 (2002) 877-883
5. Bardy G.H., Lee K.L., Mark D.B., Poole E.J., Packer D.L., Boineau R., Domanski M., Troutman C., Anderson J., Johnson G., et al., Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter defibrillator for congestive heart failure. N Engl J Med 352 (2005) 225-237
6. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 337 (1997) 1576-1584
7. Robin J., Weinberg K., Tiongson J., Carnethon M., Reddy M., Ciaccio C., Quadrini M., Hsu J., Fan J., Choi P., et al. Renal dialysis as a risk factor for appropriate therapies and mortality in implantable cardioverter-defibrillator recipients. Heart Rhythm 3 (2006) 1196-1201
8. Cuculich P.S., Sanchez J.M., Kerzner R., Greenberg S.L., Sengupta J., Chen J., Faddis M.N., Gleva M.J., Smith T.W., and Lindsay B.D. Poor prognosis for patients with chronic kidney disease despite ICD therapy for the primary prevention of sudden death. Pacing Clin Electrophysiol 30 (2007) 207-213
9. Turakhia M.P., Varosy P.D., Lee K., Tseng Z.H., Lee R., Bhadhwar N., Scheinman M., Lee B., and Olgin J.E. Impact of renal function on survival in patients with implantable cardioverter-defibrillators. Pacing Clin Electrophysiol 30 (2007) 377-384
10. Hreybe H., Razak E., and Saba S. Effect of end-stage renal failure and hemodialysis on mortality rates in implantable cardioverter-defibrillator recipients. Pacing Clin Electrophysiol 30 (2007) 1091-1095
11. Wase A., Basit A., Nazir R., Jamal A., Shah S., Khan T., Mohiuddin I., White C., Saklayen M., and McCullough P.A. Impact of chronic kidney disease upon survival among implantable cardioverter-defibrillator recipients. J Interven Card Electrophysiol 11 (2004) 199-204
12. Levy R., DellaValle A., Atav A.S., Rehman A.U., Sklar A.H., and Stamato N.J. The relationship between glomerular filtration rate and survival in patients treated with an implantable cardioverter defibrillator. Clin Cardiol 31 (2008) 265-269
13. Eckart R.E., Gula L.J., Reynolds M.R., Shry E.A., and Maisel W.H. Mortality following defibrillator implantation in patients with renal insufficiency. J Cardiovasc Electrophysiol 17 (2006) 940-943
14. DerSimonian R., and Laird N. Meta-analysis in clinical trials. Control Clin Trials 7 (1986) 177-188
15. Mantel N., and Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22 (1959) 719-748
16. Stroup D.F., Berlin J.A., Morton S.C., Olkin I., Williamson G.D., Rennie D., Moher D., Becker B.J., Sipe T.A., and Thacker S.B. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 283 (2000) 2008-2012
17. Hreybe H., Ezzeddine R., Bedi M., Barrington W., Bazaz R., Ganz L.I., Jain S., Ngwu O., London B., and Saba S. Renal insufficiency predicts time to first appropriate defibrillator shock. Am Heart J 151 (2006) 852-856
18. Herzog C.A., Li S., Weinhandl E.D., Strief J.W., Collins A.J., and Gilbertson D.T. Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators. Kidney Int 68 (2005) 818-825
19. Amin M.S., Fox A.D., Kalahasty G., Shepard R.K., Wood M.A., and Ellenbogen K.A. Benefit of primary prevention implantable cardioverter-defibrillators in the setting of chronic kidney disease: a decision model analysis. J Cardiovasc Electrophysiol 12 (2008) 1-6
20. Epstein A.E., DiMarco J.P., Ellenbogen K.A., Estes III N.A., Freedman R.A., Gettes L.S., Gillinov A.M., Gregoratos G., Jammill S.C., Hayes D.L., et al., American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemaker and Arrhythmia Devices), American Association for Thoracic Surgery, Society of Thoracic Surgeons. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemaker and Arrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol 51 (2008) e1-e61
21. Chen-Scarabelli C., and Scarabelli T.M. Chronic renal insufficiency is an independent predictor of mortality in implantable cardioverter-defibrillator recipients. Pacing Clin Electrophysiol 30 (2007) 371-376
22. Furgeson S.B., and Chonchol M. Beta-blockade in chronic dialysis patients. Semin Dial 21 (2008) 43-48
23. de Bie M.K., Lekkerkerker J.C., van Dam B., Gaasbeek A., van Buren M., Putter H., van Erven L., Bax J.J., Schalij M.J., Rabelink T.J., and Jukema J.W. Prevention of sudden cardiac death: rationale and design of the Implantable Cardioverter Defibrillators in Dialysis Patients (ICD2) trial-a prospective pilot study. Curr Med Res Opin 24 (2008) 2151-2157